Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss from immunosuppressive drugs in transplant patients can affect well-being and treatment adherence, so personalized management is important.

Nonimmunosuppressive cyclosporines might treat skin diseases by affecting cell growth.

A man had a non-cancerous, fast-growing skin lump on his arm that was removed with surgery.

γδTregs can protect hair follicles from alopecia areata and may help regrow hair.

Sacituzumab tirumotecan shows promise in treating breast cancer with manageable side effects.

A woman had a rare skin condition with recurring painful nodules that heal in 6 weeks, often without needing treatment.

Tofacitinib can cause unusual hair growth, requiring careful monitoring and possible laser hair removal.

Trastuzumab may cause tufted hair folliculitis as a side effect.

Alopecia areata is an autoimmune disease causing hair loss, and targeting macrophages may help treat it.

Tralokinumab successfully treated alopecia areata in a patient with atopic dermatitis.

Folliculotropic mycosis fungoides can look like alopecia areata.

The research developed methods to test drugs that could protect and restore hair follicle protection in a hair loss condition.

Epidermoid cysts can be better diagnosed with ultrasound by recognizing specific features and using clinical information.

Tofacitinib effectively regrows hair in alopecia universalis triggered by a virus.

The trial showed that a new under-the-tongue treatment for severe hair loss was somewhat effective in a small group of people.

Diphencyprone is effective for treating patchy hair loss in alopecia areata, but tacrolimus is not.

Keloids can form at the site of a healed herpes zoster infection, but the reason is unclear.

Pertussis toxin may contribute to hair loss in alopecia areata.

Higher TGF-β signaling may increase skin cancer risk in organ transplant recipients.

Tofacitinib can be effective in treating hair loss caused by alopecia areata.

Spontaneous keloids may be linked to nephrogenic systemic fibrosis in dialysis patients.

CD8+ T cells expand significantly in alopecia areata, suggesting new treatment targets.

Anti-IL-12/IL-23 antibody therapy effectively treats psoriasiform skin lesions in IBD patients.

Topical tofacitinib is effective and safe for treating alopecia areata.

imTA and pulse therapy are effective for alopecia areata with manageable side effects, but relapse rates need improvement.

A man developed skin lesions as a side effect of a gamma secretase inhibitor used for treating a tumor.

Pentoxifylline is a safe and effective alternative to triamcinolone acetonide for treating localized alopecia areata.

A mouse model for studying scleroderma in chronic graft-versus-host disease was successfully created.

A rare skin tumor with bone formation was successfully removed without recurrence.

Tofacitinib caused significant hair regrowth in adolescents with alopecia universalis who didn't respond to other treatments.